Jason Ryan

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Unintended consequences: the accreditation council for graduate medical education work-hour rules in practice
    Jason Ryan
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Ann Intern Med 143:82-3. 2005
  2. ncbi Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?
    Jason Ryan
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Coron Artery Dis 17:667-71. 2006
  3. ncbi Are drug-eluting stents cost-effective? It depends on whom you ask
    Jason Ryan
    Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass, USA
    Circulation 114:1736-43; discussion 1744. 2006
  4. ncbi Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study
    George Katsimaglis
    Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    J Am Coll Cardiol 45:336-42. 2005
  5. ncbi Drug eluting stents for ST-elevation myocardial infarction: risk and benefit
    Jason Ryan
    Beth Israel Deaconess Medical Center and Harvard Medical School, 1 Deaconess Road, Boston, MA 02215, USA
    J Thromb Thrombolysis 24:293-9. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Unintended consequences: the accreditation council for graduate medical education work-hour rules in practice
    Jason Ryan
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Ann Intern Med 143:82-3. 2005
  2. ncbi Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?
    Jason Ryan
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Coron Artery Dis 17:667-71. 2006
    ..In this chapter, we discuss the theoretical risks and benefits of drug-eluting stents for ST elevation acute myocardial infarction, the available data regarding their use, and the areas in which future studies are needed...
  3. ncbi Are drug-eluting stents cost-effective? It depends on whom you ask
    Jason Ryan
    Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Mass, USA
    Circulation 114:1736-43; discussion 1744. 2006
  4. ncbi Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study
    George Katsimaglis
    Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    J Am Coll Cardiol 45:336-42. 2005
    ..CONCLUSIONS: Use of statins was highly protective against perioperative cardiac complications in patients undergoing vascular surgery in this retrospective study...
  5. ncbi Drug eluting stents for ST-elevation myocardial infarction: risk and benefit
    Jason Ryan
    Beth Israel Deaconess Medical Center and Harvard Medical School, 1 Deaconess Road, Boston, MA 02215, USA
    J Thromb Thrombolysis 24:293-9. 2007
    ..This review with discuss the theoretical risks and benefits of DES for STEMI, the available data regarding their use, and the areas where future studies are needed...